Effects of fumonisin b1 on the stomach and colon cell lines in Vitro

Tehran University Medical Journal

Volumn 69, Issue 12, 2012, Pages 744-753

  Mahmoodi, Majid ^a   Alizadeh, Ali Mohammad ^a   Amini Najafi, Fatemeh ^b   Khosravi, Ali Reza ^b   Hosseini, Sayed Kazem ^c   Safari, Zahra ^c   Hydarnasab, Daryosh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adenocarcinoma; Colon; Epithelial cell; Fumonisin B1; Gastric

Indexed keywords

FUMONISIN B1; INTERLEUKIN 1BETA; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COLON ADENOCARCINOMA; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; STOMACH CANCER;

EID: 84856995132     PISSN: 16831764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Dutton MF. Fumonisins, mycotoxins of increasing importance: their nature and their effects. Pharmacol Ther 1996;70(2):137-61.
2. Oswald IP, Marin DE, Bouhet S, Pinton P, Taranu I, Accensi F. Immunotoxicological risk of mycotoxins for domestic animals. Food Addit Contam 2005;22(4):354-60.
3. Stockmann-Juvala H, Savolainen K. A review of the toxic effects and mechanisms of action of fumonisin B1. Hum Exp Toxicol 2008;27(11):799-809.
4. Merrill AH Jr, Sullards MC, Wang E, Voss KA, Riley RT. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ Health Perspect 2001;109 Suppl 2:283-9.
5. Bhandari N, Sharma RP. Fumonisin B(1)-induced alterations in cytokine expression and apoptosis signaling genes in mouse liver and kidney after an acute exposure. Toxicology 2002;172(2):81-92.
6. Riley RT, Voss K, Norred WP, Sharma RP, Wang E, Merrill Jr AH. Fumonisins: mechanism of mycotoxicity. Rev Med Vet 1998;149:617-26.
7. Bondy GS, Pestka JJ. Immunomodulation by fungal toxins. J Toxicol Environ Health B Crit Rev 2000;3(2):109-43.
8. Taranu I, Marin DE, Bouhet S, Pascale F, Bailly JD, Miller JD, et al. Mycotoxin fumonisin B1 alters the cytokine profile and decreases the vaccinal antibody titer in pigs. Toxicol Sci 2005;84(2):301-7
9. Marin DE, Taranu I, Pascale F, Lionide A, Burlacu R, Bailly JD, et al. Sex-related differences in the immune response of weanling piglets exposed to low doses of fumonisin extract. Br J Nutr 2006;95(6):1185-92.
10. Müller G, Kielstein P, Rosner H, Berndt A, Heller M, Köhler H. Studies on the influence of combined administration of ochratoxin A, fumonisin B1, deoxynivalenol and T2 toxin on immune and defence reactions in weaner pigs. Mycoses 1999;42(7-8):485-93.
11. Qureshi MA, Garlich JD, Hagler WM Jr, Weinstock D. Fusarium proliferatum culture material alters several production and immune performance parameters in White Leghorn chickens. Immunopharmacol Immunotoxicol 1995;17(4):791-804.
12. Pandolfi F, Cianci R, Pagliari D, Landolfi R, Cammarota G. Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. Mediators Inflamm 2009;2009:132028.
13. Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001;19:163-96.
14. Shirakawa F, Saito K, Bonagura CA, Galson DL, Fenton MJ, Webb AC, et al. The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol Cell Biol 1993;13(3):1332-44.
15. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett 2008;29(3):287-91.
16. Korstanje A, van Eeden S, Offerhaus JA, Waltman FL, Hartog G, Roelandse FW, et al. Comparison between serology and histology in the diagnosis of advanced gastric body atrophy: a study in a Dutch primary community. J Clin Gastroenterol 2008;42(1):18-22.
17. Zavros Y, Waghray M, Tessier A, Bai L, Todisco A, L Gumucio D, et al. Reduced pepsin A processing of sonic hedgehog in parietal cells precedes gastric atrophy and transformation. J Biol Chem 2007;282(46):33265-74.
18. Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut 2008;57(3):298-305.
19. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007;117(1):60-9.
20. Ghiasian SA, Maghsood AH, Yazdanpanah H, Shephard GS, Van Der Westhuizen L, Vismer HF, et al. Incidence of Fusarium verticillioides and levels of fumonisins in corn from main production areas in Iran. J Agric Food Chem 2006;54(16):6118-22.
21. Marasas WF, Kriek NP, Fincham JE, van Rensburg SJ. Primary liver cancer and oesophageal basal cell hyperplasia in rats caused by Fusarium moniliforme. Int J Cancer 1984;34(3):383-7.
22. Hoch RC, Schraufstätter IU, Cochrane CG. In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors. J Lab Clin Med 1996;128(2):134-45.
23. Odhav B, Adam JK, Bhoola KD. Modulating effects of fumonisin B1 and ochratoxin A on leukocytes and messenger cytokines of the human immune system. Int Immunopharmacol 2008;8(6):799-809
24. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997;112(6 Suppl):321S-329S.
25. Sansonetti PJ, Arondel J, Huerre M, Harada A, Matsushima K. Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis. Infect Immun 1999;67(3):1471-80.
26. Zachrisson K, Neopikhanov V, Wretlind B, Uribe A. Mitogenic action of tumour necrosis factor-alpha and interleukin-8 on explants of human duodenal mucosa. Cytokine 2001;15(3):148-55.
27. Maheshwari A, Lacson A, Lu W, Fox SE, Barleycorn AA, Christensen RD, et al. Interleukin-8/CXCL8 forms an autocrine loop in fetal intestinal mucosa. Pediatr Res 2004;56(2):240-9.
28. Chiba N, Masuda A, Yoshikai Y, Matsuguchi T. Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells. J Cell Physiol 2007;213(1):126-36.
29. Bouhet S, Le Dorze E, Peres S, Fairbrother JM, Oswald IP. Mycotoxin fumonisin B1 selectively down-regulates the basal IL-8 expression in pig intestine: in vivo and in vitro studies. Food Chem Toxicol 2006;44(10):1768-73.
30. Bhandari N, Raghubir P, Sharma. Modulation of selected cell signaling genes in mouse liver by fumonisin B1. Chem Biol Interact 2002;139(3):317-31.
31. Merrill AH Jr, Sullards MC, Wang E, Voss KA, Riley RT. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ Health Perspect 2001;109 Suppl 2:283-9.
32. Kouadio JH, Mobio TA, Baudrimont I, Moukha S, Dano SD, Creppy EE. Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology 2005;213(1-2):56-65.
33. Shephard GS, Thiel PG, Sydenham EW, Savard ME. Fate of a single dose of 14C-labelled fumonisin B1 in vervet monkeys. Nat Toxins 1995;3(3):145-50.
34. Prelusky DB, Trenholm HL, Rotter BA, Miller JD, Savard ME, Yeung JM, et al. Biological fate of fumonisin B1 in food-producing animals. Adv Exp Med Biol 1996;392:265-78.
35. Kato S, Kikuchi S, Nakajima S. When does gastric atrophy develop in Japanese children? Helicobacter 2008;13(4):278-81.
36. Lee Y, Jeon YC, Koo TY, Cho HS, Byun TJ, Kim TY, et al. Histological changes of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication. Korean J Gastroenterol 2007;50(5):299-305.
37. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, et al. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol 2007;42(17):21-7.
38. Chu FS, Li GY. Simultaneous occurrence of fumonisin B1 and other mycotoxins in moldy corn collected from the People's Republic of China in regions with high incidences of esophageal cancer. Appl Environ Microbiol 1994;60(3):847-52.
39. Sydenham EW, Theil PG, Marasas WFO, Shephard GS, Van Schalkwyk DJ, Koch KR. Natural occurrence of some Fusarium mycotoxins in corn from low and high esophageal cancer prevalence areas of the Transkei, Southern Africa. J Agric Food Chem 1999;38: 38:1900-3.
40. Yoshizawa T, Yamashita A, Luo Y. Fumonisin occurrence in corn from high- and low-risk areas for human esophageal cancer in China. Appl Environ Microbiol 1994;60(5):1626-9.
41. Iijima K, Koike T, Abe Y, Inomata Y, Sekine H, Imatani A, et al. Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol 2007;102(8):1603-9.